Literature DB >> 20420886

Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.

Yue-Yu Zhou1, Yong-Zhong Du, Ling Wang, Hong Yuan, Jian-Ping Zhou, Fu-Qiang Hu.   

Abstract

Stearic acid (SA) and poly (lactic-co-glycolic acid) (PLGA) grafted chitosan oligosaccharide (SA-CSO-PLGA SCP) tripolymer was synthesized via the reaction between the carboxyl group of SA or PLGA with carboxylic side group, and the amine group of CSO in the presence of 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). The degrees of amino-substitution for SA and PLGA were assayed through 2, 4, 6-trinitrobenzene sulfonic acid (TNBS) test and (13)C NMR spectrum, which were 8.15% and 5.82%, respectively; the critical micelle concentrations of SCP in PBS (pH 7.4) and deionized water (DI water) were about 34.9 and 14.5 microg/ml, respectively. Using 10-hydroxycamptothecin (HCPT) as a model drug, the drug-loaded micelles showed above 86% encapsulation efficiency, which not only enhanced the solubility of HCPT in aqueous medium markedly, but also protected the lactone ring of HCPT. Cellular uptakes of SCP micelles against A549, MCF-7 and HepG-2 tumor cells showed a faster cellular internalization. Comparing to the commercial HCPT injection, HCPT-loaded micelles showed higher cytotoxicities against A549, MCF-7 and HepG-2 cells. The increased folds were 22, 18 and 15, respectively. These results suggested the SCP could be applied as a carrier for hydrophobic drugs. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420886     DOI: 10.1016/j.ijpharm.2010.04.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Novel surfactants with diglutamic acid polar head group: drug solubilization and toxicity studies.

Authors:  Nathalie Ménard; Nicolas Tsapis; Cécile Poirier; Thomas Arnauld; Laurence Moine; Claire Gignoux; François Lefoulon; Jean-Manuel Péan; Elias Fattal
Journal:  Pharm Res       Date:  2012-03-27       Impact factor: 4.200

2.  Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.

Authors:  Xiuhua Zhao; Yuangang Zu; Ru Jiang; Ying Wang; Yong Li; Qingyong Li; Dongmei Zhao; Baishi Zu; Baoyou Zhang; Zhiqiang Sun; Xiaonan Zhang
Journal:  Int J Mol Sci       Date:  2011-04-20       Impact factor: 5.923

3.  Preparation of carboxymethylchitosan nanoparticles with Acid-sensitive bond based on solid dispersion of 10-hydroxycamptothecin.

Authors:  Risheng Yao; Lu Liu; Shengsong Deng; Weitao Ren
Journal:  ISRN Pharm       Date:  2011-07-27

4.  PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release.

Authors:  Mohammed Halayqa; Urszula Domańska
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

5.  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.

Authors:  Linjie Yang; Jingyi Hong; Jing Di; Yifei Guo; Meihua Han; Meifeng Liu; Xiangtao Wang
Journal:  Int J Nanomedicine       Date:  2017-05-12

6.  Enhanced Anti-Cancer Effect of Folate-Conjugated Olaparib Nanoparticles Combined with Radiotherapy in Cervical Carcinoma.

Authors:  Dong Li; Chuanfei Hu; Juan Yang; Yin Liao; Yue Chen; Shao Zhi Fu; Jing Bo Wu
Journal:  Int J Nanomedicine       Date:  2020-12-10

7.  Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma.

Authors:  Bo Yang; XiaoLing Ni; LongXia Chen; Heng Zhang; PeiRong Ren; Yue Feng; Yue Chen; ShaoZhi Fu; JingBo Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Polysaccharide-based micelles for drug delivery.

Authors:  Nan Zhang; Patricia R Wardwell; Rebecca A Bader
Journal:  Pharmaceutics       Date:  2013-05-27       Impact factor: 6.321

9.  Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.

Authors:  Hongyun Zhao; Meng Wu; Leilei Zhu; Yi Tian; Mingxing Wu; Yizhen Li; Liming Deng; Wei Jiang; Wei Shen; Zhigang Wang; Zhechuan Mei; Pan Li; Haitao Ran; Zhiyi Zhou; Jianli Ren
Journal:  Theranostics       Date:  2018-02-14       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.